A Retrospective, Observational Study Assessing the Incidences of Proteinuria Leading to Cessation of Bevacizumab and Ramucirumab Treatments and the Role of Renin-angiotensin System Inhibitors for Countering Proteinuria
Latest Information Update: 06 Apr 2020
At a glance
- Drugs Bevacizumab (Primary) ; Ramucirumab (Primary)
- Indications Cancer
- Focus Adverse reactions
Most Recent Events
- 06 Apr 2020 New trial record